SUPPLEMENTARY MATERIAL
Published: 19 February 2025| Version 3 | DOI: 10.17632/f29jwbgh7j.3
Contributors:
Lindsay S. Ackerman, Bethanee Schlosser, Tianyu Zhan, Vimal H. Prajapati, Scott Fretzin, Hidetoshi Takahashi, Xiaohong Huang, Heidi S. Camp, Alexa B. KimballDescription
Improvements in moderate-to-severe hidradenitis suppurativa with upadacitinib: Results from a phase 2, randomized, placebo controlled study
Files
Categories
Hidradenitis Suppurativa